SCHEMBL29979783

SCHEMBL29979783

O=C(O)c1c[nH]c2ncc(F)cc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
AXL P30530 3/20 0.43
CYP1A2 P05177 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.43
KMT2A Q03164 1/20 0.43
CSNK2A2 P19784 2/20 0.40
CSNK2B P67870 2/20 0.40
CSNK2A1 P68400 2/20 0.40
TET2 Q6N021 1/20 0.40
TET1 Q8NFU7 1/20 0.40
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ASPH Q12797 1/20 0.39
KDM8 Q8N371 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9149346 1.00 KDM4E (0.56) KDM4EAXLCYP1A2MEN1ALDH1A1
Hydrochloric Acid SCHEMBL27672178 0.98 KDM4E (0.55) KDM4EAXLCYP1A2MEN1ALDH1A1
SCHEMBL2814713 0.91 AXL (0.47) KDM4EAXLGSK3AGSK3BASPH
SCHEMBL29457338 0.87 KDM4E (0.41) KDM4EAXLALDH1A1KMT2ACSNK2A1
SCHEMBL28904824 0.87 KDM4E (0.41) KDM4EAXLALDH1A1KMT2ACSNK2A1
SCHEMBL7535408 0.84 AXL (0.58) KDM4EAXL
SCHEMBL31024826 0.82 CSNK2A1 (0.43) KDM4EAXLCYP1A2MEN1ALDH1A1
SCHEMBL10131672 0.82 CSNK2A1 (0.49) KDM4EAXLCYP1A2MEN1ALDH1A1
SCHEMBL28904865 0.80 ALDH1A1 (0.37) KDM4EAXLALDH1A1KMT2AGSK3A
SCHEMBL29980339 0.79 ALDH1A1 (0.37) KDM4EALDH1A1KMT2AGSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110520422-B Novel pyridonecarboxylic acid derivative or salt thereof 涌永制药株式会社 2023-09-05 CN disclosed
CN-109689656-B 7-substituted 1-arylnaphthyridine-3-carboxamides and their use 拜耳股份公司 2022-10-04 CN disclosed